Peripheral blood draws

PROCEDURE4 trials

Sponsors

Washington University School of Medicine

Conditions

Cancer of the PancreasDiffuse Large B Cell LymphomaExtensive-stage Small Cell Lung CancerFollicular LymphomaPancreas CancerPancreatic Cancer

Phase 1

Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

CompletedNCT03072771

Washington University School of MedicineDiffuse Large B Cell Lymphoma

Start: 2017-08-01End: 2023-10-30Updated: 2023-11-28

Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma

TerminatedNCT03121677

Washington University School of MedicineFollicular Lymphoma

Start: 2018-10-16End: 2023-08-07Updated: 2023-08-14

Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

TerminatedNCT03122106

Washington University School of MedicineCancer of the Pancreas, Pancreas Cancer, Pancreatic Cancer

Start: 2018-01-05End: 2022-08-13Updated: 2023-10-10

Phase 2

Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer

Active, not recruitingNCT04397003

Washington University School of MedicineExtensive-stage Small Cell Lung Cancer

Start: 2022-03-30End: 2029-09-30Updated: 2025-10-22

Related Papers

Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma

Blood Advances2024-05-079 citations

Blinatumomab consolidation post–autologous stem cell transplantation in patients with diffuse large B-cell lymphoma

Blood Advances2023-10-238 citations

Comprehensive Characterization of the Genetic and Neoantigen Landscapes of Follicular Lymphoma Patients Supports the Feasibility of Personalized Cancer Vaccine Treatments

Open Scholarship Institutional Repository (Washington University in St. Louis)2021-10-12

Abstract PO-56: Identification of predicted neoantigen vaccine candidates in follicular lymphoma patients

Blood Cancer Discovery2020-11-01

Identification of predicted neoantigen vaccine candidates in follicular lymphoma patients.

Journal of Clinical Oncology2020-05-20